Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity

Bouatou, Yassine; Samer, Caroline Flora; Ing Lorenzini, Kuntheavy Roseline; Daali, Youssef; Daou, Samira; Fathi, Marc; Rebsamen, Michela; Desmeules, Jules Alexandre; Calmy, Alexandra; Escher, Monica

doi:10.1186/1742-6405-11-25

Scientific article

Case report

English

Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity

ContributorsBouatou, Yassine; Samer, Caroline Flora; Ing Lorenzini, Kuntheavy Roseline; Daali, Youssef; Daou, Samira; Fathi, Marc; Rebsamen, Michela; Desmeules, Jules Alexandre; Calmy, Alexandra

; Escher, Monica

Published inAIDS research and therapy, vol. 11, 25

Publication date2014

Abstract

Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities.

Affiliation entities

Research groups

Citation (ISO format)

BOUATOU, Yassine et al. Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity. In: AIDS research and therapy, 2014, vol. 11, p. 25. doi: 10.1186/1742-6405-11-25

Article (Published version)

Identifiers

PID : unige:43677
DOI : 10.1186/1742-6405-11-25
PMID : 25120580

Journal ISSN1742-6405

664views

914downloads

Creation18/11/2014 12:19:00

First validation18/11/2014 12:19:00

Update time14/03/2023 22:29:31

Status update14/03/2023 22:29:30

Last indexation30/10/2024 21:34:08

Archive ouverte UNIGE

Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity

Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities.

Technical informations